Skip to Content

SANDOZ 620 (Rivastigmine Tartrate 4.5 mg)

Pill with imprint SANDOZ 620 is Red, Capsule-shape and has been identified as Rivastigmine Tartrate 4.5 mg. It is supplied by Sandoz Pharmaceuticals Inc..

Rivastigmine is used in the treatment of alzheimer's disease; lewy body dementia; parkinson's disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 4.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for SANDOZ 620

Rivastigmine tartrate 4.5 mg SANDOZ 620

Rivastigmine Tartrate

Imprint:
SANDOZ 620
Strength:
4.5 mg
Color:
Red
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Cholinesterase inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Sandoz Pharmaceuticals Inc.
Inactive Ingredients:
gelatin
hypromellose
magnesium stearate
microcrystalline cellulose
ferric oxide red
silicon dioxide
titanium dioxide
ferric oxide yellow
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide